Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.

Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patients carried the prevalent c.985A>G mutation in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marga Sturm, Diran Herebian, Martina Mueller, Maurice D Laryea, Ute Spiekerkoetter
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e488ed6eedc74f2f86850021d402f2e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e488ed6eedc74f2f86850021d402f2e8
record_format dspace
spelling oai:doaj.org-article:e488ed6eedc74f2f86850021d402f2e82021-11-18T07:05:23ZFunctional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.1932-620310.1371/journal.pone.0045110https://doaj.org/article/e488ed6eedc74f2f86850021d402f2e82012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23028790/?tool=EBIhttps://doaj.org/toc/1932-6203Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patients carried the prevalent c.985A>G mutation in the ACADM gene. Since the introduction of newborn screening many other mutations with unknown clinical relevance have been identified in asymptomatic newborns. In order to identify functional effects of these mutant genotypes we correlated residual MCAD (OMIM 607008) activities as measured by octanoyl-CoA oxidation in lymphocytes with both genotype and relevant medical reports in 65 newborns harbouring mutant alleles. We identified true disease-causing mutations with residual activities of 0 to 20%. In individuals carrying the c.199T>C or c.127G>A mutation on one allele, residual activities were much higher and in the range of heterozygotes (31%-60%). Therefore, both mutations cannot clearly be associated with a clinical phenotype. This demonstrates a correlation between the octanoyl-CoA oxidation rate in lymphocytes and the clinical outcome. With newborn screening, the natural course of disease is difficult to assess. The octanoyl-CoA oxidation rate, therefore, allows a risk assessment at birth and the identification of new ACADM genotypes associated with asymptomatic disease variants.Marga SturmDiran HerebianMartina MuellerMaurice D LaryeaUte SpiekerkoetterPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e45110 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marga Sturm
Diran Herebian
Martina Mueller
Maurice D Laryea
Ute Spiekerkoetter
Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
description Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (OMIM 201450) is the most common inherited disorder of fatty acid metabolism presenting with hypoglycaemia, hepatopathy and Reye-like symptoms during catabolism. In the past, the majority of patients carried the prevalent c.985A>G mutation in the ACADM gene. Since the introduction of newborn screening many other mutations with unknown clinical relevance have been identified in asymptomatic newborns. In order to identify functional effects of these mutant genotypes we correlated residual MCAD (OMIM 607008) activities as measured by octanoyl-CoA oxidation in lymphocytes with both genotype and relevant medical reports in 65 newborns harbouring mutant alleles. We identified true disease-causing mutations with residual activities of 0 to 20%. In individuals carrying the c.199T>C or c.127G>A mutation on one allele, residual activities were much higher and in the range of heterozygotes (31%-60%). Therefore, both mutations cannot clearly be associated with a clinical phenotype. This demonstrates a correlation between the octanoyl-CoA oxidation rate in lymphocytes and the clinical outcome. With newborn screening, the natural course of disease is difficult to assess. The octanoyl-CoA oxidation rate, therefore, allows a risk assessment at birth and the identification of new ACADM genotypes associated with asymptomatic disease variants.
format article
author Marga Sturm
Diran Herebian
Martina Mueller
Maurice D Laryea
Ute Spiekerkoetter
author_facet Marga Sturm
Diran Herebian
Martina Mueller
Maurice D Laryea
Ute Spiekerkoetter
author_sort Marga Sturm
title Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
title_short Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
title_full Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
title_fullStr Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
title_full_unstemmed Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants.
title_sort functional effects of different medium-chain acyl-coa dehydrogenase genotypes and identification of asymptomatic variants.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/e488ed6eedc74f2f86850021d402f2e8
work_keys_str_mv AT margasturm functionaleffectsofdifferentmediumchainacylcoadehydrogenasegenotypesandidentificationofasymptomaticvariants
AT diranherebian functionaleffectsofdifferentmediumchainacylcoadehydrogenasegenotypesandidentificationofasymptomaticvariants
AT martinamueller functionaleffectsofdifferentmediumchainacylcoadehydrogenasegenotypesandidentificationofasymptomaticvariants
AT mauricedlaryea functionaleffectsofdifferentmediumchainacylcoadehydrogenasegenotypesandidentificationofasymptomaticvariants
AT utespiekerkoetter functionaleffectsofdifferentmediumchainacylcoadehydrogenasegenotypesandidentificationofasymptomaticvariants
_version_ 1718424011891802112